XPO1 is a major nuclear exporter of many tumor suppressor and chemotherapeutic targets [49, 50], and overexpression of XPO1 has been shown to be relative to poor prognosis or resistance to chemotherapy in various cancers [51]. Here, XPO1 is linked to cancer.